MENU
NOV 12, 2020 10:00 AM PST

Representative sampling to address tumor heterogeneity

Speaker

Abstract

Ensuring that clinical tests are not affected by tumor heterogeneity requires a sampling methodology that captures the genomic, proteomic, and cellular diversity of entire solid tumors. However, today the vast majority of surgically removed solid tumor tissue is considered surgical waste and incinerated, or bio-banked as formalin fixed blocks. In fact, in a clinical survey we show that standard molecular tests use only 0.0005% of the initial tumor volume. Other fields outside of medicine such as the mining industry and political polling have solved the challenge of heterogeneity through the statistically powered process of representative sampling. We have applied the principle of representative sampling to solid tumors by homogenizing residual fixed tumor tissue not taken for pathology into a well-mixed solution across multiple tumor types including breast, NSCLC, and colon adenocarcinoma. Representative sampling followed by NGS (Rep-Seq) allows for clear discernment of clonal vs. sub-clonal variants and detects more total variants compared to single biopsies. The homogenized representative sample can be further processed to enable flow cytometry and a comprehensive quantification of infiltrating immune cells, activated fibroblasts, and the percentage of cancer cells within the tumor. Representative sampling of tumors through homogenization of fixed, unused tumor tissue enables researchers and clinicians to generate data sets that are not biased by spatial heterogeneity, and to assess the genomic and cellular diversity of solid tumors.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources